Galectin-3 and CD44v6 expression in early (T1a and T1b) breast cancer

被引：0
|
作者：
Jaratli, H [1 ]
Ali, I [1 ]
Witkiewicz, A [1 ]
Khan, A [1 ]
机构：
[1] Univ Massachusetts, Mem Med Ctr, Worcester, MA 01605 USA
来源：
MODERN PATHOLOGY | 2002年 / 15卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
149
引用
收藏
页码：39A / 39A
页数：1
相关论文
共 50 条
  • [41] Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer
    Fasano, Genevieve A.
    Bayard, Solange
    Chen, Yalei
    Varella, Leticia
    Cigler, Tessa
    Bensenhaver, Jessica
    Simmons, Rache
    Swistel, Alexander
    Marti, Jennifer
    Moore, Anne
    Andreopoulou, Eleni
    Ng, John
    Brandmaier, Andrew
    Formenti, Silvia
    Ali, Haythem
    Davis, Melissa
    Newman, Lisa
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 192 (01) : 163 - 173
  • [42] Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
    G. Cancello
    P. Maisonneuve
    N. Rotmensz
    G. Viale
    M. G. Mastropasqua
    G. Pruneri
    E. Montagna
    S. Dellapasqua
    M. Iorfida
    A. Cardillo
    P. Veronesi
    A. Luini
    M. Intra
    O. Gentilini
    E. Scarano
    A. Goldhirsch
    M. Colleoni
    Breast Cancer Research and Treatment, 2011, 127
  • [43] Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
    Cancello, G.
    Maisonneuve, P.
    Rotmensz, N.
    Viale, G.
    Mastropasqua, M. G.
    Pruneri, G.
    Montagna, E.
    Dellapasqua, S.
    Iorfida, M.
    Cardillo, A.
    Veronesi, P.
    Luini, A.
    Intra, M.
    Gentilini, O.
    Scarano, E.
    Goldhirsch, A.
    Colleoni, M.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 127 (03) : 713 - 720
  • [44] Benefit of adjuvant chemotherapy in node-negative T1a versus T1b and T1c triple-negative breast cancer
    Genevieve A. Fasano
    Solange Bayard
    Yalei Chen
    Leticia Varella
    Tessa Cigler
    Jessica Bensenhaver
    Rache Simmons
    Alexander Swistel
    Jennifer Marti
    Anne Moore
    Eleni Andreopoulou
    John Ng
    Andrew Brandmaier
    Silvia Formenti
    Haythem Ali
    Melissa Davis
    Lisa Newman
    Breast Cancer Research and Treatment, 2022, 192 : 163 - 173
  • [45] CD44v6 expression does not predict outcome in early colorectal cancer
    Tilsed, JVT
    Andreyev, HJN
    Cunningham, D
    Norman, AR
    Schneider, HJ
    Sampson, SA
    Clarke, P
    GASTROENTEROLOGY, 1996, 110 (04) : A603 - A603
  • [46] Six-Year Follow-Up of Patients With Microinvasive, T1a, and T1b Breast Carcinoma
    G. Bruce Mann
    Elisa Rush Port
    Christine Rizza
    Lee K. Tan
    Patrick I. Borgen
    Kimberly J. Van Zee
    Annals of Surgical Oncology, 1999, 6 : 591 - 598
  • [47] Prognosis in women with small (T1mic,T1a,T1b) node-negative operable breast cancer by immunohistochemically selected subtypes
    Cancello, G.
    Maisonneuve, P.
    Rotmensz, N.
    Viale, G.
    Mastropasqua, M. G.
    Pruneri, G.
    Montagna, E.
    Dellapasqua, S.
    Iorfida, M.
    Cardillo, A.
    Veronesi, P.
    Luini, A.
    Intra, M.
    Gentilini, O. D.
    Scarano, E.
    Pastrello, D.
    Goldhirsch, A.
    Colleoni, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [48] Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: A systematic review
    George Sgourakis
    Ines Gockel
    Hauke Lang
    World Journal of Gastroenterology, 2013, (09) : 1424 - 1437
  • [49] High Dual Expression of the Biomarkers CD44v6/α2β1 and CD44v6/PD-L1 Indicate Early Recurrence after Colorectal Hepatic Metastasectomy
    Wrana, Friederike
    Doetzer, Katharina
    Pruefer, Martin
    Werner, Jens
    Mayer, Barbara
    CANCERS, 2022, 14 (08)
  • [50] Surgery (T1a, T1b1-T1b3, FST, Cancer in pregnancy)
    Cibula, D.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S843 - S843
12345